Fuan Pharmaceutical (Group) Co., Ltd.

300194

CNE1000011G4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
4.08 ^CNY	+0.25%		-0.49%	-6.85%

05-28	Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024	CI
05-27	Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Chongqing Yadi Investment Co., Ltd. completed the acquisition of 5.01% stake in Fuan Pharmaceutical Co., Ltd. from Wang Tianxiang.

November 24, 2019

Chongqing Yadi Investment Co., Ltd. agreed to acquire 5.01% stake in Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) from Wang Tianxiang for approximately CNY 330 million on November 4, 2019. As per terms, Chongqing Yadi Investment Co., Ltd. will acquire 59.6 million shares at CNY 5.5 per share. Chongqing Yadi Investment Co., Ltd. completed the acquisition of 5.01% stake in Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) from Wang Tianxiang on November 25, 2019.

Latest news about Fuan Pharmaceutical (Group) Co., Ltd.

Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024	05-28	CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	05-27	CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	04-24	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Fuan Pharm Unit's Hemorrhage Drug Gets Registration Certificate from China's Drug Regulator	04-07	MT
Drugs of Fuan Pharma's Unit Passes Regulatory Evaluation	02-22	MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Fuan Pharma Unit Gets Marketing Approval for Two Drugs	23-06-26	MT
Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023	23-05-05	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-31	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Fuan Pharmaceutical Registers New Respiratory Drug	22-10-10	MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Fuan Pharmaceutical Co., Ltd. Announces Management Appointments	21-12-13	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Fuan Pharmaceutical Co., Ltd.(XSEC:300194) dropped from S&P Global BMI Index	21-06-21	CI
Fuan Pharmaceutical Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021	21-05-07	CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020	21-04-29	CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI

Chart Fuan Pharmaceutical (Group) Co., Ltd.

Duration

Period

Chart Fuan Pharmaceutical (Group) Co., Ltd.

More charts

Company Profile

Fuan Pharmaceutical (Group) Co.,Ltd. is a China-based company principally engaged in the sales of Active Pharmaceutical Ingredients (APIs) and intermediates, preparations and pharmaceuticals. The Company's pharmaceutical products mainly include antibiotics, anti-tumor medicines, respiratory system medicines and specialty medicines. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
FUAN PHARMACEUTICAL (GROUP) CO., LTD.	-6.85%	670M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-10.33%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B